A 39-year-old woman presented by ambulance 20 minutes after ingesting 4 tablespoons of sodium nitrite in a suicide attempt. Presenting vital signs included: pulse 139 beats/min, blood pressure 117/48 mm Hg, respiratory rate 24 breaths/minute, pulse oximetry 83% on 15 L/minute oxygen and Glasgow Coma Scale 15. Examination revealed cyanosis and pallor (Figures 1 and 2) with bounding peripheral pulses. Five minutes after arrival, the patient had generalized tonic-clonic seizures and was intubated. Activated charcoal and antidotal therapy were administered, and gastric lavage was performed. Blood appeared dark brown on arterial puncture (Figure 3).
FIGURE 2. Cyanotic foot compared to the hand of the emergency department physician
Based on the history of sodium nitrite ingestion and clinical examination, 2 mg/kg methylene blue was administered. Methemoglobin level returned at 73%. The patient rapidly stabilized after antidotal therapy, and methemoglobin levels normalized 3 hours later. She was extubated on hospital day 3, neurologically intact.
Intentional sodium nitrite exposures appear to be increasing in the United States, possibly due to online communities recommending this as a painless suicide method.1 Sodium nitrite, a readily available oxidizing agent used in food preservation, causes methemoglobinemia by oxidizing ferrous (2+) to ferric iron (3+) in hemoglobin. This decreases the blood oxygen carrying capacity, prevents oxygen off-loading in hypoxic tissues, and results in characteristic chocolate-brown blood.2 Methylene blue reduces methemoglobin back to hemoglobin and also causes blue-green urine (Figure 4).3 Patients are frequently symptomatic with methemoglobin levels >30%, and death rapidly ensues when levels exceed 70%, although survival has been reported with levels as high as 92%.4 Blood methemoglobin levels confirm the diagnosis, but because sodium nitrite ingestion may cause rapid cardiac arrest5 and early methylene blue administration is associated with good outcomes,6 severe methemoglobinemia should be diagnosed clinically to facilitate rapid methylene blue administration.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
© 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Details

1 Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA; Department of Emergency Medicine, Regions Hospital, St. Paul, Minnesota, USA
2 Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA
3 Department of Emergency Medicine, Hennepin Healthcare, Minneapolis, Minnesota, USA; Minnesota Poison Control System, Minneapolis, Minnesota, USA